Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Vitamin D is linked to hair health, but more research is needed for its use in treating female hair loss.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with seborrheic dermatitis often have lower vitamin D levels.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Redheaded people may have evolved to efficiently make vitamin D in areas with less sunlight.

Redheaded people have higher levels of a vitamin D precursor, suggesting red hair may be an adaptation for better vitamin D synthesis in areas with less sunlight.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Some calcium supplements have more calcium than their labels say, and a few have less.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Testosterone therapy increases bone density in older men with low testosterone levels.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.